SEARCHING
Find out where the grant data comes from, and what years and philanthropies are included.
Information, tips and tricks for making your search more successful
Search
Grants – search grants based on their
stated purpose
Recipients – search all grants to
a particular recipient
Funders – search for organizations or
individuals that are funding grants
People – search for people who benefit
from grant funds
Website – search the website for specific
text
Advanced search – specifiy multiple
criteria
All-in-one search – search the website
and the database at the same time for specific text
MEDIA TRANSPARENCY
Sign-up for our newsletter
Only registered visitors are allowed to email content or post comments
Your help is essential to this website
|
AROUND THE WEB
NY Times
December 22, 2005
Philip Shenon
Susan Finston of the Institute for Policy Innovation...is just the sort of opinion maker coveted by the drug industry.
In an opinion article in The Financial Times on Oct. 25, she called for patent protection in poor countries for drugs and biotechnology products. In an article last month in the European edition of The Wall Street Journal, she called for efforts to block developing nations from violating patents on AIDS medicines and other drugs.
Both articles identified her as a "research associate" at the institute. Neither mentioned that, as recently as August, Ms. Finston was registered as a lobbyist for the Pharmaceutical Research and Manufacturers of America, the drug industry's trade group. Nor was there mention of her work this fall in creating the American Bioindustry Alliance, a group underwritten largely by drug companies.
Also see:
Institute for Policy Innovation Earlier: Op-Eds for sale
Read the story >
|
|
